Q3 2022 Pharming Group NV Earnings Call Transcript
Hello, and welcome to Pharming's 9 Months 2022 Results Call. My name is Lauren, and I will be coordinating your call today. (Operator Instructions)
I will now hand you over to our host, Dr. Sijmen de Vries, CEO, to begin. Dr. Sijmen, please go ahead.
Thank you very much, Lauren. Good morning, ladies and gentlemen, or good afternoon. I'm very pleased to have you here at the 9 months '22 Results Call. And with me here is my colleagues Anurag Relan, our Chief Medical Officer; and Jeroen Wakkerman, our Chief Financial Officer.
And before we do that, of course, I would like to -- you to look at that forward-looking statement slides because this presentation may contain forward-looking statements that, of course, are based upon our current estimations and beliefs and expectations and as you know, things -- circumstances could change towards the future.
Okay. And having said that, I would like to switch to the next slide, where you see probably a picture of 3
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |